Detected ·
RadioNano Therapeutics
¥200M—
RadioNano Therapeutics has received an additional JPY 200 million investment from Kyoto iCAP at the first close of its Series B round, with Mitsui Kinzoku also participating, to support clinical trial preparations and manufacturing for its boron drug candidate RN-501 used in BNCT cancer radiotherapy.
- Website
- —
- —
- Amount
- ¥200 000 000 JPY
- Stage
- —
- Event
- Funding round
- Detected
- 2026-10-13 08:10:37 UTC
- Signal ID
- c21799a2-e8d0-414c-a62b-f5d71ca0887a
As the API returns it
{
"id": "c21799a2-e8d0-414c-a62b-f5d71ca0887a",
"created_at": "2026-10-13T08:10:37.607782Z",
"company_name": "RadioNano Therapeutics",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 200000000,
"funding_currency": "JPY",
"funding_stage": null,
"message": "*RadioNano Therapeutics has received an additional JPY 200 million investment from Kyoto iCAP at the first close of its Series B round, with Mitsui Kinzoku also participating, to support clinical trial preparations and manufacturing for its boron drug candidate RN-501 used in BNCT cancer radiotherapy.*"
}